Stock Report

All about this stock under one free report Last Updated: 07-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

IsoRay Inc. (DE) (ISR)

Stock Card factsheet share-fund-plan-icon

$0.69

up-down-arrow $0.00 (-0.19%)

As on 21-Apr-2023 09:30EDT

Market cap

info icon

$107 Mln

Revenue (TTM)

info icon

$8 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

IsoRay Inc. (DE) (ISR) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
NYSE
NYSE

Stock Range

Today’s Range

Low: 0.65 High: 0.69

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-6 Mln

  • ROEROE information

    -0.2 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    46.53

  • EV/EBITDAEV/EBITDA information

    1.2

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    278,657,984

10 Years Aggregate

CFO

$-44.35 Mln

EBITDA

$-47.37 Mln

Net Profit

$-49.54 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
IsoRay Inc. (DE) (ISR)
175.9 5.9 146.3 102.9 6.2 9.4 2.3
BSE Sensex*
-8.1 5.0 -6.9 -3.5 8.4 9.7 11.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 21-Apr-2023  |  *As on 07-May-2026  |  #As on 26-Oct-2023
Company
2022
2021
2020
2019
2018
2017
2016
IsoRay Inc. (DE) (ISR)
-35.9 -13.3 -27.9 108.1 -24.8 -31.2 -38.1
S&P Small-Cap 600
-17.4 25.3 9.6 20.9 -9.7 11.7 24.7
BSE Sensex
4.4 22.0 15.8 14.4 5.9 27.9 1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About IsoRay Inc. (DE) (ISR)

Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers...  CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.  Read more

  • CEO & Director

    Ms. Lori A. Holmes-Woods

  • COO & VP of HR

    Ms. Jennifer Streeter

  • Headquarters

    Richland, WA

  • Website

    https://isoray.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for IsoRay Inc. (DE) (ISR)

The share price of IsoRay Inc (DE) (ISR) is $0.69 (NYSE) as of 21-Apr-2023 09:30 EDT. IsoRay Inc (DE) (ISR) has given a return of 6.19% in the last 3 years.

Since, TTM earnings of IsoRay Inc (DE) (ISR) is negative, P/E ratio is not available.
The P/B ratio of IsoRay Inc (DE) (ISR) is 0.74 times as on 21-Apr-2023, a 76 discount to its peers’ median range of 3.09 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
--
--
2021
--
--
2020
--
--
2019
--
--
2018
--
--

The 52-week high and low of IsoRay Inc (DE) (ISR) are Rs -- and Rs -- as of 07-May-2026.

IsoRay Inc (DE) (ISR) has a market capitalisation of $ 107 Mln as on 21-Apr-2023. As per SEBI classification, it is a Small Cap company.

Before investing in IsoRay Inc (DE) (ISR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.